# Disparities in Emergency Contraceptive Metabolism Dictate Efficacy

> **NCT05674513** · PHASE4 · RECRUITING · sponsor: **Oregon Health and Science University** · enrollment: 140 (estimated)

## Conditions studied

- Contraceptive Usage

## Interventions

- **DRUG:** Ulipristal acetate

## Key facts

- **NCT ID:** NCT05674513
- **Lead sponsor:** Oregon Health and Science University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-01-09
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2024-08-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05674513

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05674513, "Disparities in Emergency Contraceptive Metabolism Dictate Efficacy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05674513. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*